...
首页> 外文期刊>European journal of gastroenterology and hepatology >The impact of amalgam dental fillings on the frequency of Helicobacter pylori infection and H. pylori eradication rates in patients treated with concomitant, quadruple, and levofloxacin-based therapies
【24h】

The impact of amalgam dental fillings on the frequency of Helicobacter pylori infection and H. pylori eradication rates in patients treated with concomitant, quadruple, and levofloxacin-based therapies

机译:汞齐充填对同时,四联和左氧氟沙星治疗的患者中幽门螺杆菌感染频率和幽门螺杆菌根除率的影响

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Background and aimMercury exposure is encountered most commonly in individuals with amalgam fillings. The toxic, bactericidal, and immunosuppressive effects of mercury are well known. Furthermore, multiple antibiotic resistance can be transferred, together with mercury resistance. The aim of this study was to investigate the frequency of Helicobacter pylori infection in dyspeptic patients with amalgam fillings and the effect of the amalgam fillings on H. pylori eradication rates in these patients.Patients and methodsFour hundred and seventy-five patients who presented with dyspeptic complaints and underwent upper gastrointestinal endoscopy and gastric biopsy were included in this study. One hundred and sixty-nine (35.6%) patients were negative and 306 (64.4%) patients were positive for H. pylori. All of the participants underwent dental examinations in a blinded manner. The participants were divided into two groups on the basis of the presence of amalgam fillings. The H. pylori-positive patients were divided randomly into three subgroups: patients who received concomitant therapy (CT) (rabeprazole-amoxicillin-clarithromycin-metronidazole for 14 days; n=122); patients who received quadruple therapy (QT) (rabeprazole-tetracycline-metronidazole-colloidal bismuth subcitrate for 10 days; n=97); and patients who received levofloxacin-based therapy (LT) (rabeprazole-amoxicillin-levofloxacin for 10 days; n=87). Eradication success was detected by a urea breath test 6 weeks after the end of treatment.ResultsThe frequency of H. pylori infection was significantly lower in the filling group compared with the nonfilling group (53.7 and 78.8%, respectively; P<0.001). The eradication rates in the CT, QT, and LT groups were 65.5, 67.0, and 58.6%, respectively, in the intention-to-treat (ITT) analysis and 69.6, 70.7, and 62.2%, respectively, in the per-protocol (PP) analysis. In all of the H. pylori-positive patients and separately in the CT and LT groups, the eradication rates were significantly lower in the filling group compared with the nonfilling group. However, in the QT group, there was no significant difference between the patients with and without fillings (P=0.001, 0.003, 0.012, 0.14, respectively). Logistic regression analysis showed that the absence of amalgam filling exerts independent effects on the increased frequency of H. pylori infection and increased rate of H. pylori eradication.ConclusionThis is the first study to show a lower frequency of H. pylori colonization in patients with amalgam fillings than without and that H. pylori eradication rates are lower in patients with amalgam fillings compared to those without.
机译:背景和目标汞合金填充物个体最常见汞暴露。汞的毒性,杀菌和免疫抑制作用是众所周知的。此外,多种抗药性可以与耐汞性一起转移。这项研究的目的是调查患有汞合金充填的消化不良患者的幽门螺杆菌感染频率以及汞合金充填对这些患者的幽门螺杆菌根除率的影响。患者和方法475例消化不良的患者本研究包括主诉和接受上消化道内镜检查和胃活检。幽门螺杆菌为169例(35.6%)阴性,306例(64.4%)阳性。所有参与者都以盲目方式接受了牙科检查。根据汞合金填充物的存在将参与者分为两组。幽门螺杆菌阳性患者随机分为三个亚组:接受伴随治疗(CT)的患者(雷贝拉唑-阿莫西林-克拉霉素-甲硝唑治疗14天; n = 122);接受四联疗法(QT)的患者(雷贝拉唑-四环素-甲硝唑-胶体枸ism酸铋10天; n = 97);接受左氧氟沙星治疗(LT)的患者(雷贝拉唑-阿莫西林-左氧氟沙星治疗10天; n = 87)。治疗结束后6周,通过尿素呼气试验成功根除。结果:与未填充组相比,填充组的幽门螺杆菌感染率显着降低(分别为53.7和78.8%; P <0.001)。 CT,QT和LT组的根除率在意向性治疗(ITT)分析中分别为65.5%,67.0%,70.7%和62.2%,在每项协议中(PP)分析。在所有幽门螺杆菌阳性患者中,分别在CT和LT组中,填充组的根除率明显低于未填充组。然而,在QT组中,有充填和没有充填的患者之间没有显着差异(分别为P = 0.001、0.003、0.012、0.14)。 Logistic回归分析表明,汞齐填充的缺乏对幽门螺杆菌感染的增加频率和幽门螺杆菌根除率的增加具有独立的影响。结论这是第一项显示汞齐症患者幽门螺杆菌定植频率较低的研究与没有汞填充物相比,汞合金填充物患者的幽门螺杆菌根除率更低。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号